ELIZABETH MOORE: Open Payments
NPI 1366789471 · FERNANDINA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 16 payments from 9 companies in 2025. Trend: 2023 $52 · 2024 $199 · 2025 $679
Food & beverage: $580Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $310 |
| GENZYME CORPORATION | 3 | $179 |
| Medtronic, Inc. | 2 | $54 |
| Optinose US, Inc. | 1 | $26 |
| Olympus America Inc. | 1 | $25 |
| Stryker Corporation | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Smith+Nephew, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: DUPIXENT, PROPEL, Xhance, LIGASURE, AUDION ET DILATION SYSTEM, TEZSPIRE, STRAVIX, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
